

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 5.11358764 |
| 2 | apoptotic cell clearance (GO:0043277) | 4.15993454 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.12829873 |
| 4 | * cell adhesion mediated by integrin (GO:0033627) | 3.98489724 |
| 5 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.95329818 |
| 6 | protein retention in ER lumen (GO:0006621) | 3.93347590 |
| 7 | cell-substrate junction assembly (GO:0007044) | 3.77252011 |
| 8 | barbed-end actin filament capping (GO:0051016) | 3.76145931 |
| 9 | low-density lipoprotein particle clearance (GO:0034383) | 3.73966454 |
| 10 | mesodermal cell differentiation (GO:0048333) | 3.66422549 |
| 11 | hypotonic response (GO:0006971) | 3.64129082 |
| 12 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.62206624 |
| 13 | collagen fibril organization (GO:0030199) | 3.52873588 |
| 14 | protein hydroxylation (GO:0018126) | 3.48230979 |
| 15 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.37781484 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 3.35422839 |
| 17 | endodermal cell differentiation (GO:0035987) | 3.35065247 |
| 18 | COPII vesicle coating (GO:0048208) | 3.30901096 |
| 19 | skin morphogenesis (GO:0043589) | 3.27130538 |
| 20 | negative regulation of anoikis (GO:2000811) | 3.18856048 |
| 21 | chondrocyte proliferation (GO:0035988) | 3.18671079 |
| 22 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.16609670 |
| 23 | protein localization to endosome (GO:0036010) | 3.15732266 |
| 24 | desmosome organization (GO:0002934) | 3.13689521 |
| 25 | negative regulation of fatty acid transport (GO:2000192) | 3.10354215 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 3.10233603 |
| 27 | protein carboxylation (GO:0018214) | 3.08528763 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.08528763 |
| 29 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.07048834 |
| 30 | vesicle coating (GO:0006901) | 3.02619889 |
| 31 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.02085406 |
| 32 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.97483403 |
| 33 | type B pancreatic cell proliferation (GO:0044342) | 2.94768600 |
| 34 | epoxygenase P450 pathway (GO:0019373) | 2.94608556 |
| 35 | regulation of early endosome to late endosome transport (GO:2000641) | 2.93397215 |
| 36 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.90317055 |
| 37 | protein heterotrimerization (GO:0070208) | 2.89969369 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 2.88219247 |
| 39 | positive regulation of p38MAPK cascade (GO:1900745) | 2.87986080 |
| 40 | wound healing, spreading of epidermal cells (GO:0035313) | 2.87845328 |
| 41 | plasma membrane repair (GO:0001778) | 2.86357415 |
| 42 | positive regulation of extracellular matrix organization (GO:1903055) | 2.84442425 |
| 43 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.82809546 |
| 44 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.79858863 |
| 45 | hyaluronan catabolic process (GO:0030214) | 2.79263393 |
| 46 | positive regulation of hemostasis (GO:1900048) | 2.78718419 |
| 47 | positive regulation of blood coagulation (GO:0030194) | 2.78718419 |
| 48 | basement membrane organization (GO:0071711) | 2.74327832 |
| 49 | positive regulation of receptor recycling (GO:0001921) | 2.72802937 |
| 50 | fibrinolysis (GO:0042730) | 2.72687030 |
| 51 | cellular copper ion homeostasis (GO:0006878) | 2.71733492 |
| 52 | regulation of cholesterol storage (GO:0010885) | 2.71254514 |
| 53 | adherens junction assembly (GO:0034333) | 2.70189917 |
| 54 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.69754068 |
| 55 | axon extension involved in axon guidance (GO:0048846) | 2.69754068 |
| 56 | cellular response to vitamin (GO:0071295) | 2.68124436 |
| 57 | muscle cell migration (GO:0014812) | 2.66890613 |
| 58 | extracellular matrix assembly (GO:0085029) | 2.66784671 |
| 59 | regulation of fibrinolysis (GO:0051917) | 2.65357517 |
| 60 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.63595978 |
| 61 | positive regulation of osteoblast proliferation (GO:0033690) | 2.63463664 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.62662931 |
| 63 | renal filtration (GO:0097205) | 2.62157084 |
| 64 | extracellular fibril organization (GO:0043206) | 2.59609962 |
| 65 | kidney mesenchyme development (GO:0072074) | 2.59274794 |
| 66 | focal adhesion assembly (GO:0048041) | 2.58445382 |
| 67 | cell-substrate adherens junction assembly (GO:0007045) | 2.58445382 |
| 68 | regulation of plasminogen activation (GO:0010755) | 2.57819133 |
| 69 | * collagen metabolic process (GO:0032963) | 2.57340656 |
| 70 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.56746326 |
| 71 | positive regulation of coagulation (GO:0050820) | 2.56530767 |
| 72 | * extracellular matrix organization (GO:0030198) | 2.56354132 |
| 73 | regulation of anoikis (GO:2000209) | 2.56272684 |
| 74 | * regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.56232769 |
| 75 | L-phenylalanine catabolic process (GO:0006559) | 2.55507999 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.55507999 |
| 77 | * extracellular structure organization (GO:0043062) | 2.55269231 |
| 78 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.54801568 |
| 79 | * positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.54685765 |
| 80 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.54603547 |
| 81 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.53350276 |
| 82 | * membrane protein ectodomain proteolysis (GO:0006509) | 2.53051739 |
| 83 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.52835663 |
| 84 | wound healing, spreading of cells (GO:0044319) | 2.52327115 |
| 85 | glial cell migration (GO:0008347) | 2.52182147 |
| 86 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.51797515 |
| 87 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51170064 |
| 88 | complement activation, alternative pathway (GO:0006957) | 2.51048198 |
| 89 | cellular response to interferon-alpha (GO:0035457) | 2.50327373 |
| 90 | * collagen catabolic process (GO:0030574) | 2.49055784 |
| 91 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.48364033 |
| 92 | virion attachment to host cell (GO:0019062) | 2.47931654 |
| 93 | adhesion of symbiont to host cell (GO:0044650) | 2.47931654 |
| 94 | mammary gland epithelial cell proliferation (GO:0033598) | 2.47382009 |
| 95 | 4-hydroxyproline metabolic process (GO:0019471) | 2.47367992 |
| 96 | actin filament depolymerization (GO:0030042) | 2.46536384 |
| 97 | regulation of protein activation cascade (GO:2000257) | 2.46515975 |
| 98 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 2.46220545 |
| 99 | regulation of complement activation (GO:0030449) | 2.46141318 |
| 100 | stress fiber assembly (GO:0043149) | 2.46022308 |
| 101 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.44308141 |
| 102 | regulation of metalloenzyme activity (GO:0048552) | 2.43702307 |
| 103 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.42941597 |
| 104 | chondrocyte development (GO:0002063) | 2.41920989 |
| 105 | L-phenylalanine metabolic process (GO:0006558) | 2.41602579 |
| 106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.41602579 |
| 107 | keratan sulfate catabolic process (GO:0042340) | 2.41165301 |
| 108 | * extracellular matrix disassembly (GO:0022617) | 2.40242952 |
| 109 | sulfur amino acid catabolic process (GO:0000098) | 2.39974126 |
| 110 | endothelial cell morphogenesis (GO:0001886) | 2.39964149 |
| 111 | negative regulation of stem cell proliferation (GO:2000647) | 2.39950570 |
| 112 | adhesion of symbiont to host (GO:0044406) | 2.39573057 |
| 113 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.38599291 |
| 114 | hippo signaling (GO:0035329) | 2.37948834 |
| 115 | wound healing (GO:0042060) | 2.37849737 |
| 116 | glomerular basement membrane development (GO:0032836) | 2.37794887 |
| 117 | * multicellular organismal metabolic process (GO:0044236) | 2.37231359 |
| 118 | pinocytosis (GO:0006907) | 2.37103336 |
| 119 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36884176 |
| 120 | fibril organization (GO:0097435) | 2.36422188 |
| 121 | cortical actin cytoskeleton organization (GO:0030866) | 2.35557763 |
| 122 | membrane raft organization (GO:0031579) | 2.33810069 |
| 123 | * multicellular organismal catabolic process (GO:0044243) | 2.33233593 |
| 124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.30927261 |
| 125 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30204857 |
| 126 | growth hormone receptor signaling pathway (GO:0060396) | 2.30108263 |
| 127 | glomerular visceral epithelial cell development (GO:0072015) | 2.30085013 |
| 128 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.29827322 |
| 129 | response to lipoprotein particle (GO:0055094) | 2.29227286 |
| 130 | COPI coating of Golgi vesicle (GO:0048205) | 2.27535562 |
| 131 | Golgi transport vesicle coating (GO:0048200) | 2.27535562 |
| 132 | epithelial cell-cell adhesion (GO:0090136) | 2.26525861 |
| 133 | glomerular filtration (GO:0003094) | 2.26506817 |
| 134 | platelet degranulation (GO:0002576) | 2.26037534 |
| 135 | cellular response to vitamin D (GO:0071305) | 2.25832318 |
| 136 | regulation of cholesterol homeostasis (GO:2000188) | 2.25525280 |
| 137 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.23742468 |
| 138 | positive regulation of fatty acid oxidation (GO:0046321) | 2.21565648 |
| 139 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.21275599 |
| 140 | cysteine metabolic process (GO:0006534) | 2.21240806 |
| 141 | iron ion import (GO:0097286) | 2.20237794 |
| 142 | protein localization to cell surface (GO:0034394) | 2.20218401 |
| 143 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.19294726 |
| 144 | peptidyl-proline hydroxylation (GO:0019511) | 2.18998312 |
| 145 | lipoprotein metabolic process (GO:0042157) | 2.18819189 |
| 146 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.16547959 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.15677493 |
| 148 | mannose metabolic process (GO:0006013) | 2.15219592 |
| 149 | semaphorin-plexin signaling pathway (GO:0071526) | 2.14041657 |
| 150 | endocardial cushion development (GO:0003197) | 2.13691839 |
| 151 | regulation of macrophage cytokine production (GO:0010935) | 2.12900046 |
| 152 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.12482682 |
| 153 | substrate-dependent cell migration (GO:0006929) | 2.11787723 |
| 154 | positive regulation of lipid catabolic process (GO:0050996) | 2.11732870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.33467792 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.97958421 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.54324482 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.14893493 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.13452239 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.98763900 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.94296659 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77029338 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62304481 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.53087965 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.36777302 |
| 12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.27246079 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.14690948 |
| 14 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.13743786 |
| 15 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.13743786 |
| 16 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.11203292 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09421230 |
| 18 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.08644248 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05551116 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.04771271 |
| 21 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.01809170 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.01521091 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96247926 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.95398704 |
| 25 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94296049 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.91362596 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.87083880 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85464405 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.85059444 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80942600 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.79931157 |
| 32 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75685181 |
| 33 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.75381047 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74240459 |
| 35 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.72354427 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69067102 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.60749498 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59442685 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56926825 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54513033 |
| 41 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.51340727 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51144751 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48736880 |
| 44 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.42310555 |
| 45 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.41240843 |
| 46 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.41240843 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.40525778 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.39897076 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.37876499 |
| 50 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.36332099 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35434802 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33519627 |
| 53 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.33367888 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33202679 |
| 55 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32176917 |
| 56 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.31598104 |
| 57 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31578645 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29897859 |
| 59 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25946968 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25362047 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25294901 |
| 62 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.24779308 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24665250 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24416617 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23690228 |
| 66 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.23166009 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22984853 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21772220 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20814447 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20671828 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20671828 |
| 72 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.20284076 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18719046 |
| 74 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16580102 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15758296 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15293508 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14645683 |
| 78 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14249175 |
| 79 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13164720 |
| 80 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.11299935 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09949311 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.09838221 |
| 83 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.09327990 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08340525 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05669994 |
| 86 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04440024 |
| 87 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02418411 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02026594 |
| 89 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00949795 |
| 90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00470011 |
| 91 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00300119 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00150263 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98589683 |
| 94 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.97450151 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97395290 |
| 96 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.96949688 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95942775 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95257566 |
| 99 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95203495 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95074405 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95024676 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94905442 |
| 103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94805001 |
| 104 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94492343 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93868559 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93483879 |
| 107 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93185593 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91120464 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90540735 |
| 110 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90174687 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89491212 |
| 112 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88383808 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.88213722 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87996354 |
| 115 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86228385 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.86141190 |
| 117 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86123444 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85666563 |
| 119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85185827 |
| 120 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.84651421 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82716116 |
| 122 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82588380 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80651943 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.80534285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.59264569 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 4.26386969 |
| 3 | MP0005275_abnormal_skin_tensile | 3.73629887 |
| 4 | MP0001958_emphysema | 2.79865166 |
| 5 | MP0005503_abnormal_tendon_morphology | 2.67645709 |
| 6 | MP0003279_aneurysm | 2.40870222 |
| 7 | MP0005623_abnormal_meninges_morphology | 2.40291327 |
| 8 | MP0004272_abnormal_basement_membrane | 2.37556837 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.31385615 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.19308169 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.16746318 |
| 12 | MP0009384_cardiac_valve_regurgitation | 2.15204529 |
| 13 | MP0005360_urolithiasis | 2.05956122 |
| 14 | MP0003941_abnormal_skin_development | 2.05954001 |
| 15 | MP0003300_gastrointestinal_ulcer | 1.89228727 |
| 16 | MP0003091_abnormal_cell_migration | 1.82656355 |
| 17 | MP0002295_abnormal_pulmonary_circulatio | 1.80370249 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.73522285 |
| 19 | MP0009840_abnormal_foam_cell | 1.72272680 |
| 20 | MP0005023_abnormal_wound_healing | 1.67070961 |
| 21 | MP0003252_abnormal_bile_duct | 1.64815671 |
| 22 | MP0005257_abnormal_intraocular_pressure | 1.60659654 |
| 23 | MP0003195_calcinosis | 1.55088098 |
| 24 | MP0001849_ear_inflammation | 1.53506893 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.53135101 |
| 26 | MP0006054_spinal_hemorrhage | 1.49716556 |
| 27 | MP0002060_abnormal_skin_morphology | 1.49525483 |
| 28 | MP0005083_abnormal_biliary_tract | 1.48117446 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.45942713 |
| 30 | MP0005365_abnormal_bile_salt | 1.40642293 |
| 31 | MP0004233_abnormal_muscle_weight | 1.39272058 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.37919314 |
| 33 | MP0004858_abnormal_nervous_system | 1.36475714 |
| 34 | MP0000733_abnormal_muscle_development | 1.36257795 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.35144741 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.34902534 |
| 37 | MP0003045_fibrosis | 1.33998989 |
| 38 | MP0002896_abnormal_bone_mineralization | 1.30320320 |
| 39 | MP0002168_other_aberrant_phenotype | 1.29671596 |
| 40 | MP0000604_amyloidosis | 1.28074275 |
| 41 | MP0000762_abnormal_tongue_morphology | 1.27285445 |
| 42 | MP0003690_abnormal_glial_cell | 1.25395102 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.22236111 |
| 44 | MP0000767_abnormal_smooth_muscle | 1.21968411 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.21379780 |
| 46 | MP0004130_abnormal_muscle_cell | 1.21367424 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.16406825 |
| 48 | MP0000537_abnormal_urethra_morphology | 1.16399804 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.14927194 |
| 50 | MP0005164_abnormal_response_to | 1.14320363 |
| 51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.13243659 |
| 52 | MP0000858_altered_metastatic_potential | 1.12687498 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.12464109 |
| 54 | MP0005508_abnormal_skeleton_morphology | 1.11616728 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.10376016 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.09662744 |
| 57 | MP0005451_abnormal_body_composition | 1.06394416 |
| 58 | MP0001243_abnormal_dermal_layer | 1.03857250 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.03286099 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.03066698 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.01976366 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.01891807 |
| 63 | MP0005409_darkened_coat_color | 1.01617992 |
| 64 | MP0005165_increased_susceptibility_to | 1.01502750 |
| 65 | MP0003303_peritoneal_inflammation | 0.99539180 |
| 66 | MP0000343_altered_response_to | 0.99241904 |
| 67 | MP0005332_abnormal_amino_acid | 0.97576699 |
| 68 | MP0005197_abnormal_uvea_morphology | 0.96622964 |
| 69 | MP0005375_adipose_tissue_phenotype | 0.95291908 |
| 70 | MP0002108_abnormal_muscle_morphology | 0.93849130 |
| 71 | MP0001542_abnormal_bone_strength | 0.93486109 |
| 72 | MP0003828_pulmonary_edema | 0.92564430 |
| 73 | MP0000920_abnormal_myelination | 0.92309594 |
| 74 | MP0003075_altered_response_to | 0.91341408 |
| 75 | MP0000003_abnormal_adipose_tissue | 0.91249984 |
| 76 | MP0005390_skeleton_phenotype | 0.89714995 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 0.88831383 |
| 78 | MP0004084_abnormal_cardiac_muscle | 0.88587709 |
| 79 | MP0003385_abnormal_body_wall | 0.87956389 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 0.87658408 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.87016397 |
| 82 | MP0005248_abnormal_Harderian_gland | 0.85922553 |
| 83 | MP0006082_CNS_inflammation | 0.85783210 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 0.85568977 |
| 85 | MP0010030_abnormal_orbit_morphology | 0.85091288 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 0.85072852 |
| 87 | MP0005193_abnormal_anterior_eye | 0.85006746 |
| 88 | MP0002090_abnormal_vision | 0.84761148 |
| 89 | MP0003329_amyloid_beta_deposits | 0.84659499 |
| 90 | MP0009053_abnormal_anal_canal | 0.83789428 |
| 91 | MP0000750_abnormal_muscle_regeneration | 0.82242516 |
| 92 | MP0000467_abnormal_esophagus_morphology | 0.82088452 |
| 93 | MP0000747_muscle_weakness | 0.81922413 |
| 94 | MP0003436_decreased_susceptibility_to | 0.81777356 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.81256602 |
| 96 | MP0005408_hypopigmentation | 0.80309092 |
| 97 | MP0000609_abnormal_liver_physiology | 0.80139919 |
| 98 | MP0000569_abnormal_digit_pigmentation | 0.79861698 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.79626417 |
| 100 | MP0005621_abnormal_cell_physiology | 0.79606284 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.79412254 |
| 102 | MP0000249_abnormal_blood_vessel | 0.78541977 |
| 103 | MP0002128_abnormal_blood_circulation | 0.76819673 |
| 104 | MP0003448_altered_tumor_morphology | 0.74913341 |
| 105 | MP0000627_abnormal_mammary_gland | 0.74061178 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.73332778 |
| 107 | MP0004883_abnormal_blood_vessel | 0.72449353 |
| 108 | MP0003634_abnormal_glial_cell | 0.72228683 |
| 109 | MP0005501_abnormal_skin_physiology | 0.71658092 |
| 110 | MP0002933_joint_inflammation | 0.71530127 |
| 111 | MP0001666_abnormal_nutrient_absorption | 0.71337427 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.71297191 |
| 113 | MP0010386_abnormal_urinary_bladder | 0.70666206 |
| 114 | MP0000751_myopathy | 0.70504027 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.70234645 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.70225593 |
| 117 | MP0001614_abnormal_blood_vessel | 0.70110140 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.70096870 |
| 119 | MP0000749_muscle_degeneration | 0.70053778 |
| 120 | MP0002133_abnormal_respiratory_system | 0.69711712 |
| 121 | MP0005388_respiratory_system_phenotype | 0.69711712 |
| 122 | MP0002115_abnormal_skeleton_extremities | 0.69647249 |
| 123 | MP0008004_abnormal_stomach_pH | 0.69630033 |
| 124 | MP0010771_integument_phenotype | 0.69448792 |
| 125 | MP0003942_abnormal_urinary_system | 0.69398160 |
| 126 | MP0003755_abnormal_palate_morphology | 0.69086911 |
| 127 | MP0000432_abnormal_head_morphology | 0.68968151 |
| 128 | MP0001915_intracranial_hemorrhage | 0.68783122 |
| 129 | MP0002282_abnormal_trachea_morphology | 0.68407534 |
| 130 | MP0006138_congestive_heart_failure | 0.66587103 |
| 131 | MP0009250_abnormal_appendicular_skeleto | 0.66517866 |
| 132 | MP0000163_abnormal_cartilage_morphology | 0.66442512 |
| 133 | MP0002113_abnormal_skeleton_development | 0.66405040 |
| 134 | MP0008260_abnormal_autophagy | 0.66058880 |
| 135 | MP0000579_abnormal_nail_morphology | 0.63834820 |
| 136 | MP0002796_impaired_skin_barrier | 0.63476027 |
| 137 | MP0003868_abnormal_feces_composition | 0.62686360 |
| 138 | MP0004947_skin_inflammation | 0.60814252 |
| 139 | MP0000759_abnormal_skeletal_muscle | 0.59622598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 6.07638372 |
| 2 | Protrusio acetabuli (HP:0003179) | 5.41220123 |
| 3 | Peritonitis (HP:0002586) | 3.98777308 |
| 4 | Aortic dissection (HP:0002647) | 3.95841445 |
| 5 | Aortic aneurysm (HP:0004942) | 3.53820093 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.49801651 |
| 7 | Shallow orbits (HP:0000586) | 3.47151288 |
| 8 | Ankle contracture (HP:0006466) | 3.43929106 |
| 9 | Cervical subluxation (HP:0003308) | 3.39142407 |
| 10 | Deep venous thrombosis (HP:0002625) | 3.31755816 |
| 11 | Atrophic scars (HP:0001075) | 3.19352948 |
| 12 | Broad metatarsal (HP:0001783) | 3.14851934 |
| 13 | Osteolytic defects of the hand bones (HP:0009699) | 2.97859218 |
| 14 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.97859218 |
| 15 | Myocardial infarction (HP:0001658) | 2.92803670 |
| 16 | Soft skin (HP:0000977) | 2.89217688 |
| 17 | Dilatation of the ascending aorta (HP:0005111) | 2.85844132 |
| 18 | Xanthomatosis (HP:0000991) | 2.76823044 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 2.75296463 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.75296463 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.75296463 |
| 22 | Mitral valve prolapse (HP:0001634) | 2.73167973 |
| 23 | Vascular tortuosity (HP:0004948) | 2.66874096 |
| 24 | Increased connective tissue (HP:0009025) | 2.64575633 |
| 25 | Fragile skin (HP:0001030) | 2.63761207 |
| 26 | Blue sclerae (HP:0000592) | 2.61951599 |
| 27 | Bladder diverticulum (HP:0000015) | 2.59361458 |
| 28 | Axonal loss (HP:0003447) | 2.57849427 |
| 29 | Wormian bones (HP:0002645) | 2.54897218 |
| 30 | Vertebral compression fractures (HP:0002953) | 2.53888267 |
| 31 | Type 1 muscle fiber predominance (HP:0003803) | 2.53129292 |
| 32 | Mitral stenosis (HP:0001718) | 2.49483204 |
| 33 | Complement deficiency (HP:0004431) | 2.48222262 |
| 34 | Spinal rigidity (HP:0003306) | 2.45788384 |
| 35 | Arterial tortuosity (HP:0005116) | 2.43595229 |
| 36 | Wrist flexion contracture (HP:0001239) | 2.41228143 |
| 37 | Abnormality of dentin (HP:0010299) | 2.39880241 |
| 38 | Aneurysm (HP:0002617) | 2.38870505 |
| 39 | Skin nodule (HP:0200036) | 2.31814187 |
| 40 | Short nail (HP:0001799) | 2.28926070 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.28492517 |
| 42 | Mitral regurgitation (HP:0001653) | 2.28417726 |
| 43 | Infantile muscular hypotonia (HP:0008947) | 2.23076899 |
| 44 | Natal tooth (HP:0000695) | 2.22875045 |
| 45 | Cardiovascular calcification (HP:0011915) | 2.21904924 |
| 46 | Ulnar bowing (HP:0003031) | 2.21066520 |
| 47 | Genu recurvatum (HP:0002816) | 2.20392455 |
| 48 | Absent frontal sinuses (HP:0002688) | 2.19920024 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.17278713 |
| 50 | Aortic regurgitation (HP:0001659) | 2.17175322 |
| 51 | Follicular hyperkeratosis (HP:0007502) | 2.16947370 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.16091016 |
| 53 | Nuclear cataract (HP:0100018) | 2.15900443 |
| 54 | Round ear (HP:0100830) | 2.14445082 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.12995752 |
| 56 | Upper limb amyotrophy (HP:0009129) | 2.12995752 |
| 57 | Joint laxity (HP:0001388) | 2.12146266 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.10351665 |
| 59 | Broad face (HP:0000283) | 2.10235800 |
| 60 | Hyperextensible skin (HP:0000974) | 2.09851578 |
| 61 | Hyporeflexia of lower limbs (HP:0002600) | 2.09521625 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09404671 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.09404671 |
| 64 | Scapular winging (HP:0003691) | 2.07852672 |
| 65 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07105969 |
| 66 | Turricephaly (HP:0000262) | 2.05944681 |
| 67 | Abnormality of complement system (HP:0005339) | 2.05067101 |
| 68 | Abnormal delivery (HP:0001787) | 2.04031202 |
| 69 | Ectopia lentis (HP:0001083) | 2.03593332 |
| 70 | Buphthalmos (HP:0000557) | 2.03306244 |
| 71 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01611671 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 1.99169498 |
| 73 | Hematochezia (HP:0002573) | 1.97947255 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 1.97940281 |
| 75 | Hydroxyprolinuria (HP:0003080) | 1.97940281 |
| 76 | Tetraparesis (HP:0002273) | 1.97861797 |
| 77 | Thin bony cortex (HP:0002753) | 1.96033930 |
| 78 | Nephritis (HP:0000123) | 1.95886281 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95545726 |
| 80 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95374496 |
| 81 | Hypoalphalipoproteinemia (HP:0003233) | 1.94983463 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 1.94952751 |
| 83 | Camptodactyly of toe (HP:0001836) | 1.94492142 |
| 84 | Neurofibrillary tangles (HP:0002185) | 1.92302068 |
| 85 | Cerebral inclusion bodies (HP:0100314) | 1.92135450 |
| 86 | Hyperacusis (HP:0010780) | 1.91718169 |
| 87 | Abnormality of carpal bone ossification (HP:0006257) | 1.91165981 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90377678 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90377678 |
| 90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90377678 |
| 91 | Aortic valve stenosis (HP:0001650) | 1.89510538 |
| 92 | Abnormality of oral frenula (HP:0000190) | 1.88602917 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.88068747 |
| 94 | Spinal cord lesions (HP:0100561) | 1.87855852 |
| 95 | Syringomyelia (HP:0003396) | 1.87855852 |
| 96 | Ovoid vertebral bodies (HP:0003300) | 1.87473983 |
| 97 | Abnormal ossification of hand bones (HP:0005921) | 1.84155092 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.84141290 |
| 99 | Tibial bowing (HP:0002982) | 1.84070778 |
| 100 | Femoral bowing (HP:0002980) | 1.84062872 |
| 101 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.84043228 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 1.83942735 |
| 103 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.83309875 |
| 104 | Bowel diverticulosis (HP:0005222) | 1.83202504 |
| 105 | Ankyloglossia (HP:0010296) | 1.82385457 |
| 106 | Flat acetabular roof (HP:0003180) | 1.82102266 |
| 107 | Right ventricular cardiomyopathy (HP:0011663) | 1.81749660 |
| 108 | Spondylolisthesis (HP:0003302) | 1.81267249 |
| 109 | Epidermoid cyst (HP:0200040) | 1.81224287 |
| 110 | Bowing of the arm (HP:0006488) | 1.79072899 |
| 111 | Bowed forearm bones (HP:0003956) | 1.79072899 |
| 112 | Long toe (HP:0010511) | 1.78221760 |
| 113 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78142989 |
| 114 | Back pain (HP:0003418) | 1.77908419 |
| 115 | Coronal craniosynostosis (HP:0004440) | 1.77650475 |
| 116 | Neonatal short-limb short stature (HP:0008921) | 1.77529760 |
| 117 | Vertebral arch anomaly (HP:0008438) | 1.77528855 |
| 118 | Coxa vara (HP:0002812) | 1.76927763 |
| 119 | Muscle fiber splitting (HP:0003555) | 1.76461408 |
| 120 | Abnormality of the acetabulum (HP:0003170) | 1.75726921 |
| 121 | Breech presentation (HP:0001623) | 1.75197572 |
| 122 | Overgrowth (HP:0001548) | 1.75180672 |
| 123 | Esophageal varix (HP:0002040) | 1.74844439 |
| 124 | Biconcave vertebral bodies (HP:0004586) | 1.74635320 |
| 125 | Vascular calcification (HP:0004934) | 1.74568367 |
| 126 | Subacute progressive viral hepatitis (HP:0006572) | 1.74011046 |
| 127 | Glomerulosclerosis (HP:0000096) | 1.73945908 |
| 128 | Elbow flexion contracture (HP:0002987) | 1.73755693 |
| 129 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.73425703 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.73150948 |
| 131 | Abnormality of skull ossification (HP:0002703) | 1.73002704 |
| 132 | Radial bowing (HP:0002986) | 1.72548328 |
| 133 | Increased mean platelet volume (HP:0011877) | 1.71235731 |
| 134 | Wide anterior fontanel (HP:0000260) | 1.70456171 |
| 135 | Spastic diplegia (HP:0001264) | 1.69603839 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.66542488 |
| 137 | Protruding ear (HP:0000411) | 1.64979561 |
| 138 | Pterygium (HP:0001059) | 1.64522594 |
| 139 | Joint stiffness (HP:0001387) | 1.64119217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 3.84539494 |
| 2 | TRIB3 | 3.77825745 |
| 3 | DDR2 | 2.93150743 |
| 4 | ERN1 | 2.84687124 |
| 5 | PDGFRA | 2.77286517 |
| 6 | IRAK3 | 2.62237213 |
| 7 | PKN2 | 2.56360090 |
| 8 | LATS1 | 2.38644395 |
| 9 | SIK1 | 2.32213688 |
| 10 | MET | 2.32005701 |
| 11 | EPHB1 | 2.06986249 |
| 12 | RIPK1 | 1.99292663 |
| 13 | BMX | 1.89039791 |
| 14 | PTK6 | 1.77952546 |
| 15 | FRK | 1.75847838 |
| 16 | TRPM7 | 1.72900154 |
| 17 | PTK2 | 1.66341696 |
| 18 | SCYL2 | 1.58489120 |
| 19 | NEK9 | 1.57147588 |
| 20 | EPHA2 | 1.56774404 |
| 21 | MST1R | 1.53512061 |
| 22 | PAK3 | 1.52115482 |
| 23 | NTRK1 | 1.51559874 |
| 24 | PAK2 | 1.51288799 |
| 25 | FER | 1.46829079 |
| 26 | CAMK1D | 1.44800543 |
| 27 | LRRK2 | 1.44314528 |
| 28 | TGFBR2 | 1.39600461 |
| 29 | PDGFRB | 1.38022756 |
| 30 | LIMK1 | 1.25756033 |
| 31 | EPHA3 | 1.21921579 |
| 32 | EPHB2 | 1.20014434 |
| 33 | STK39 | 1.19747151 |
| 34 | ERBB4 | 1.17743884 |
| 35 | JAK1 | 1.17724904 |
| 36 | MOS | 1.15877490 |
| 37 | PIM2 | 1.13054914 |
| 38 | STK3 | 1.10994587 |
| 39 | FGFR4 | 1.09130836 |
| 40 | LATS2 | 1.08545636 |
| 41 | CAMK1G | 1.07741030 |
| 42 | DMPK | 1.04688638 |
| 43 | FGFR2 | 1.02786191 |
| 44 | ARAF | 1.01262570 |
| 45 | TBK1 | 0.97126338 |
| 46 | CDC42BPA | 0.94630177 |
| 47 | TESK1 | 0.94414348 |
| 48 | PAK4 | 0.92650659 |
| 49 | STK38 | 0.91661543 |
| 50 | CDK12 | 0.86898510 |
| 51 | RET | 0.86843770 |
| 52 | STK38L | 0.85743713 |
| 53 | MAP3K2 | 0.85265447 |
| 54 | PBK | 0.85041543 |
| 55 | MAP3K12 | 0.84565466 |
| 56 | ABL2 | 0.83915549 |
| 57 | PIK3CA | 0.83491697 |
| 58 | FGFR1 | 0.80612764 |
| 59 | MAP2K1 | 0.79874918 |
| 60 | NME2 | 0.79757092 |
| 61 | ROCK1 | 0.79392292 |
| 62 | PRKD1 | 0.78225457 |
| 63 | KSR1 | 0.76123365 |
| 64 | NEK1 | 0.76042307 |
| 65 | PIK3CG | 0.75545788 |
| 66 | KSR2 | 0.74290514 |
| 67 | GRK7 | 0.73655141 |
| 68 | EIF2AK1 | 0.72748892 |
| 69 | MTOR | 0.72615996 |
| 70 | PTK2B | 0.72113524 |
| 71 | BCKDK | 0.71727642 |
| 72 | PAK6 | 0.69876746 |
| 73 | GSK3A | 0.69539674 |
| 74 | STK10 | 0.69470845 |
| 75 | CDK8 | 0.69083540 |
| 76 | FLT3 | 0.68892462 |
| 77 | INSR | 0.68410337 |
| 78 | WNK4 | 0.67987684 |
| 79 | ROCK2 | 0.67473562 |
| 80 | CSK | 0.67186212 |
| 81 | TAOK3 | 0.66687287 |
| 82 | PRKCH | 0.66441308 |
| 83 | FGR | 0.65791390 |
| 84 | TYK2 | 0.64070787 |
| 85 | CAMKK1 | 0.63680980 |
| 86 | MAP3K3 | 0.63611962 |
| 87 | PRKG2 | 0.63598414 |
| 88 | DYRK1B | 0.63246391 |
| 89 | PDK2 | 0.61986016 |
| 90 | MELK | 0.60709284 |
| 91 | BCR | 0.60531268 |
| 92 | EGFR | 0.59010516 |
| 93 | MAP3K8 | 0.58221860 |
| 94 | MAP3K14 | 0.57994398 |
| 95 | ICK | 0.57322549 |
| 96 | MYLK | 0.57172544 |
| 97 | PDPK1 | 0.55401315 |
| 98 | PRKD2 | 0.54956239 |
| 99 | AKT3 | 0.54368325 |
| 100 | OXSR1 | 0.53735203 |
| 101 | PRKD3 | 0.53678247 |
| 102 | ILK | 0.51922650 |
| 103 | MAP3K13 | 0.51091405 |
| 104 | TAOK2 | 0.51043056 |
| 105 | CDK6 | 0.48954381 |
| 106 | BMPR2 | 0.48787001 |
| 107 | FGFR3 | 0.48162830 |
| 108 | RPS6KA2 | 0.47411233 |
| 109 | WNK1 | 0.46189085 |
| 110 | SRC | 0.46185395 |
| 111 | CAMKK2 | 0.46119522 |
| 112 | MAP3K6 | 0.44825725 |
| 113 | LMTK2 | 0.44677667 |
| 114 | IGF1R | 0.44597391 |
| 115 | JAK2 | 0.43987467 |
| 116 | RPS6KA4 | 0.43138132 |
| 117 | CAMK2G | 0.42992675 |
| 118 | EEF2K | 0.42264502 |
| 119 | ABL1 | 0.42129759 |
| 120 | MAP2K3 | 0.41641807 |
| 121 | JAK3 | 0.40627206 |
| 122 | STK24 | 0.39108893 |
| 123 | PLK2 | 0.37877857 |
| 124 | CSF1R | 0.37108171 |
| 125 | FYN | 0.36481099 |
| 126 | CLK1 | 0.35914469 |
| 127 | ERBB3 | 0.35534992 |
| 128 | CDK9 | 0.35001671 |
| 129 | PRKCE | 0.34580093 |
| 130 | KIT | 0.34472981 |
| 131 | INSRR | 0.33939538 |
| 132 | CAMK2D | 0.33913178 |
| 133 | EIF2AK3 | 0.31762521 |
| 134 | SMG1 | 0.31404727 |
| 135 | CAMK2B | 0.29672278 |
| 136 | MAP3K9 | 0.29532116 |
| 137 | MAPKAPK3 | 0.28382435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46722102 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.22783873 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15977212 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15244265 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.02350606 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85696365 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.80228714 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 1.74349946 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.71464435 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 1.68565658 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64408874 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64017037 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63799932 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.63460004 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.55249202 |
| 16 | Amoebiasis_Homo sapiens_hsa05146 | 1.53463276 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.51912854 |
| 18 | Malaria_Homo sapiens_hsa05144 | 1.50057890 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46622515 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44537032 |
| 21 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42478884 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37249119 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36479268 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33085289 |
| 25 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.30942569 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.28169002 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27981572 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27796873 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27582319 |
| 30 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15139224 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.15086212 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12119744 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.09646616 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07604666 |
| 35 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07511677 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.06575177 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05290499 |
| 38 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.04122929 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.04051472 |
| 40 | Bladder cancer_Homo sapiens_hsa05219 | 1.02183260 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01729702 |
| 42 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01610155 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01251301 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00733039 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98509909 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98148367 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97744471 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97550649 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96421685 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96407931 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94022689 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93916868 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.91379140 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89947282 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89887545 |
| 56 | Pathways in cancer_Homo sapiens_hsa05200 | 0.88865402 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87817227 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87726000 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.86720668 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86153357 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85507586 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.85441640 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84187312 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83004792 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81500910 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.81157832 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80375335 |
| 68 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79767163 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79672611 |
| 70 | Axon guidance_Homo sapiens_hsa04360 | 0.76567034 |
| 71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76148086 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76107885 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75894769 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.73491901 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71784279 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.71668708 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70999330 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70772756 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.69754340 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68726209 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66600861 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66385389 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65295633 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.65136602 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64754266 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64661723 |
| 87 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64578133 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.63975173 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63458114 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63329999 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62858208 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62403140 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62077181 |
| 94 | Tight junction_Homo sapiens_hsa04530 | 0.61011056 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60909288 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60133795 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59441134 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58990859 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58455681 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58316431 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57094934 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.56616480 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.56261668 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56236799 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55957091 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55863519 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55859175 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55420575 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.54509936 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.54094721 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54017163 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.53931241 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53475527 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53319214 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52398387 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.52298219 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52095881 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52055009 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51695925 |
| 120 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50508805 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50461109 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50444183 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.50433415 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50020016 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49862100 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.49673474 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48478984 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47289452 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.47154207 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.47020281 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46739779 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46594081 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46488042 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46226279 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45727777 |
| 136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45474485 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45294616 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45025538 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.44741671 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43702756 |
| 141 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43440039 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43392272 |
| 143 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41910223 |
| 144 | Lysine degradation_Homo sapiens_hsa00310 | 0.40149962 |
| 145 | Melanogenesis_Homo sapiens_hsa04916 | 0.39261125 |
| 146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37583909 |
| 147 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.37213191 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36046226 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34302168 |

